Next-generation sequencing of urologic cancers: Next is now

European Urology

Volumn 66, Issue 1, 2014, Pages 4-7

  Real, Francisco X ^a,b   Boutros, Paul C ^c,d,e   Malats, Núria ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BRCA1 PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; NUCLEAR RECEPTOR COREPRESSOR; UBIQUITIN PROTEIN LIGASE E3; DNA;

BLADDER CANCER; CANCER PROGNOSIS; CANCER STAGING; CHROMOSOME ABERRATION; CHROMOSOME SEGREGATION; DNA METHYLATION; GENE MUTATION; GENETIC PROCEDURES; HISTONE METHYLATION; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY CARCINOMA; MELANOMA; NEXT GENERATION SEQUENCING; NOTE; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; URINARY TRACT CANCER; BLADDER TUMOR; GENETICS; KIDNEY TUMOR; MALE; NUCLEOTIDE SEQUENCE; PROCEDURES; PROSTATE TUMOR;

CARCINOMA, RENAL CELL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HUMANS; KIDNEY NEOPLASMS; MALE; PROSTATIC NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84902120152     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.03.028     Document Type: Editorial

References (23)

1. T.J. Hudson, W. Anderson, and A. Artez et al. International network of cancer genome projects Nature 464 2010 993 998
2. G.L. Dalgliesh, K. Furge, and C. Greenman et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Nature 463 2010 360 363
3. I. Varela, P. Tarpey, and K. Raine et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma Nature 469 2011 539 542
4. S. Peña-Llopis, S. Vega-Rubín-de-Celis, and A. Liao et al. BAP1 loss defines a new class of renal cell carcinoma Nat Genet 44 2012 751 759
5. A.A. Hakimi, I. Ostrovnaya, and B. Reva et al. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network Clin Cancer Res 19 2013 3259 3267
6. P. Kapur, S. Peña-Llopis, and A. Christie et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation Lancet Oncol 14 2013 159 167
7. Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 499 2013 43 49
8. Y. Sato, T. Yoshizato, and Y. Shiraishi et al. Integrated molecular analysis of clear-cell renal cell carcinoma Nat Genet 45 2013 860 867
9. Y. Gui, G. Guo, and Y. Huang et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder Nat Genet 43 2011 875 878
10. G. Guo, X. Sun, and C. Chen et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation Nat Genet 45 2013 1459 1463
11. Cancer Genome Atlas Research Network Comprehensive molecular characterization of urothelial bladder carcinoma Nature 507 2014 315 322
12. C. Balbás-Martínez, A. Sagrera, and E. Carrillo-de-Santa- Pau et al. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy Nat Genet 45 2013 1464 1469
13. G. Iyer, A.J. Hanrahan, and M.I. Milowsky et al. Genome sequencing identifies a basis for everolimus sensitivity Science 338 2012 221
14. M.F. Berger, M.S. Lawrence, and F. Demichelis et al. The genomic complexity of primary human prostate cancer Nature 470 2011 214 220
15. C.E. Barbieri, S.C. Baca, and M.S. Lawrence et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer Nat Genet 44 2012 685 689
16. J. Lindberg, I.G. Mills, and D. Klevebring et al. The mitochondrial and autosomal mutation landscapes of prostate cancer Eur Urol 63 2013 702 708
17. S.C. Baca, D. Prandi, and M.S. Lawrence et al. Punctuated evolution of prostate cancer genomes Cell 153 2013 666 677
18. C.S. Grasso, Y.M. Wu, and D.R. Robinson et al. The mutational landscape of lethal castration-resistant prostate cancer Nature 487 2012 239 243
19. J. Weischenfeldt, R. Simon, and L. Feuerbach et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer Cancer Cell 23 2013 159 170
20. M. Gerlinger, A.J. Rowan, and S. Horswell et al. Intratumour heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med. 366 2012 883 892
21. X. Xu, Y. Hou, and X. Yin et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor Cell 148 2012 886 895
22. M.L. Hoang, C.H. Chen, and V.S. Sidorenko et al. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing Sci Transl Med 5 2013 197ra102
23. S.L. Poon, S.T. Pang, and J.R. McPherson et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool Sci Transl Med 5 2013 197ra101